Drug Trial Radar · NCT05937178
Real-world Study Optimizing Nucleotide-analogues
Last checked: Nov 19, 2026Latest source record: Jul 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20,000
Planned (sponsor's estimate)
Start
Jan 31, 2023
Primary completion
Jan 31, 2029
Study completion Jan 31, 2029
Sponsor
- Lead sponsor
- Huashan HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The First Affiliated Hospital of Anhui Medical University; Anhui Provincial Hospital; Beijing YouAn Hospital; Peking University People's Hospital; Peking University First Hospital; Xiamen Hospital of Traditional Chinese Medicine; First Affiliated Hospital of Fujian Medical University; LanZhou University; Third Affiliated Hospital, Sun Yat-Sen University; First Affiliated Hospital of Guangxi Medical University; The Affiliated Hospital Of Guizhou Medical University; Hainan General Hospital; Hebei Medical University Third Hospital; The First Affiliated Hospital of Henan University of Traditional Chinese Medicine; Henan Provincial People's Hospital; The Second Affiliated Hospital of Harbin Medical University; Tongji Hospital; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Renmin Hospital of Wuhan University; Central South University; Xiangya Hospital of Central South University; The First Hospital of Jilin University; the Second Hospital of Nangjing; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; The First Affiliated Hospital with Nanjing Medical University; The Affiliated Hospital of Xuzhou Medical University; The First Affiliated Hospital of Nanchang University; Shengjing Hospital; Qingdao Sixth People's Hospital; Shandong Provincial Hospital; The Second Hospital of Shandong University; The First Affiliated Hospital of Shanxi Medical University; Tang-Du Hospital; First Affiliated Hospital Xi'an Jiaotong University; Ruijin Hospital; West China Hospital; Tianjin Second People's Hospital; First Affiliated Hospital of Xinjiang Medical University; The First People's Hospital of Yunnan; Shulan (Hangzhou) Hospital; Zhejiang University; Southwest Hospital, China; The Second Affiliated Hospital of Chongqing Medical University; Sichuan Provincial People's Hospital
- First posted
- Jul 10, 2023
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this multicenter, observational, prospective study is to observe and compare different anti-viral treatment strategies in a real-world cohort of patients with CHB managed in routine clinical settings in China. The main questions it aims to answer are: 1. To evaluate the benefits of initiating first-line nucleos(t)ide analogue in patients with chronic HBV infection who are recommended in the updated Chinese Guideline 2022, but not recommended in the Chinese Guideline 2019. 2. To evaluate the Chinese Guideline recommends initiation of treatment, but at least one foreign authoritative guideline (eg. AASLD, EASL) does not recommend the benefit of initiating first-line nucleos(t)ide analogue in patients with chronic HBV infection who initiate treatment. 3. To compare the treatment effect of different alternatives with patients who have partial response after treatment with first-line nucleos(t)ide analogues.
Conditions
- Hepatitis B, Chronic
Interventions
ETV/TAF/TDF/TMF/IFNDrug
peginterferon alpha or nucleos(t)ide alone are decided by patients' doctors according to their conditions, instead of extra interventions brought by the study
ETV/TAF/TDF/TMFDrug
peginterferon alpha or nucleos(t)ide alone are decided by patients' doctors according to their conditions, instead of extra interventions brought by the study
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of patients with HBV DNA <20 IU/mlTime frame: Week 48
- The proportion of patients with HBV DNA <20 IU/mlTime frame: Week 96
- The proportion of patients with HBV DNA <20 IU/mlTime frame: Week 144
- Change from baseline in Estimated Glomerular Filtration Rate by the Cockcroft-Gault Formula (eGFR-CG)Time frame: Baseline
- Change from baseline in Estimated Glomerular Filtration Rate by the Cockcroft-Gault Formula (eGFR-CG)Time frame: Week 48
- Change from baseline in Estimated Glomerular Filtration Rate by the Cockcroft-Gault Formula (eGFR-CG)Time frame: Week 96
- Change from baseline in Estimated Glomerular Filtration Rate by the Cockcroft-Gault Formula (eGFR-CG)Time frame: Week 144
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
Huashan Hospital
Shanghai, China · Recruiting
Anhui Provincial Hospital
Hefei, Anhui, China · Not yet recruiting
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China · Not yet recruiting
Beijing YouAn Hospita
Beijing, Beijing Municipality, China · Not yet recruiting
Peking University First Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University People's Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China · Not yet recruiting
the Southwest Hospital of AMU
Chongqing, Chongqing Municipality, China · Not yet recruiting
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China · Not yet recruiting
Xiamen Hospital of Traditional Chinese Medicine
Xiamen, Fujian, China · Not yet recruiting
the First Hospital of Lanzhou University
Lanzhou, Gansu, China · Not yet recruiting
First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China · Not yet recruiting
The Affiliated Hospital Of Guizhou Medical University
Guiyang, Guizhou, China · Not yet recruiting
The Second Affiliated Hospital of Harbin Medical University
Ha’erbin, Ha'erbin, China · Not yet recruiting
Hainan General Hospital
Haikou, Hainan, China · Not yet recruiting
the Third Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Not yet recruiting
Henan Provincial People's Hospital
Zhengzhou, Henan, China · Not yet recruiting
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Zhengzhou, Henan, China · Not yet recruiting
Renmin Hospital of Wuhan University
Wuhan, Hubei, China · Not yet recruiting
Tongji Hospital
Wuhan, Hubei, China · Not yet recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
the Second Xiangya Hospital of Central South University
Changsha, Hunan, China · Not yet recruiting
Xiangya Hospital Central South University
Changsha, Hunan, China · Not yet recruiting
Jiangsu Province Hospital
Nanjing, Jiangsu, China · Not yet recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China · Not yet recruiting
the Second Hospital of Nangjing
Nanjing, Jiangsu, China · Not yet recruiting
the Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China · Recruiting
the First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Not yet recruiting
the First Bethune Hospital Of Jilin University
Changchun, Jilin, China · Not yet recruiting
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China · Not yet recruiting
Tangdu Hospital, The Fourth Military Medical University
Xi'an, Shaanxi, China · Not yet recruiting
the First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China · Not yet recruiting
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China · Not yet recruiting
The Second Hospital of Shandong University
Jinan, Shandong, China · Not yet recruiting
No. 6 People's Hospital of Qingdao
Qingdao, Shandong, China · Not yet recruiting
Ruijin Hospital
Shanghai, Shanghai Municipality, China · Not yet recruiting
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China · Not yet recruiting
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China · Not yet recruiting
West China Hospital of Sichuan University
Chengdu, Sichuan, China · Not yet recruiting
Tianjin Second People's Hospital
Tianjin, Tianjin Municipality, China · Not yet recruiting
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.